These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2039374)

  • 1. Effect of chemotherapy on glioma metabolism.
    Maker HS
    Arch Neurol; 1991 Jun; 48(6):569-70. PubMed ID: 2039374
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain imaging of glucose utilization in cerebral tumors.
    Di Chiro G
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():185-97. PubMed ID: 3875134
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography in patients with glioma. A predictor of prognosis.
    Alavi JB; Alavi A; Chawluk J; Kushner M; Powe J; Hickey W; Reivich M
    Cancer; 1988 Sep; 62(6):1074-8. PubMed ID: 3261622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
    Rozental JM; Levine RL; Nickles RJ; Dobkin JA
    Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of regional cerebral glucose metabolism demonstrated in situ in rat brain by 19F NMR rotating frame zeugmatography: one dimensional chemical shift imaging of normal and gliosarcoma implanted brain.
    Nakada T; Kwee IL
    Magn Reson Imaging; 1987; 5(4):259-66. PubMed ID: 3116361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
    Newmark ME; Theodore WH; Sato S; De La Paz R; Patronas N; Brooks R; Jabbari B; Di Chiro G
    Arch Neurol; 1983 Oct; 40(10):607-10. PubMed ID: 6615267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
    Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
    Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
    J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of brain tumors.
    Rozental JM
    Neurol Clin; 1991 May; 9(2):287-305. PubMed ID: 1944100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
    Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
    Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [14C]-deoxyglucose metabolism and peripheral benzodiazepine receptor binding in rat C6 glioma.
    Richfield EK; Ciliax BJ; Starosta-Rubinstein SR; McKeever PE; Penney JB; Young AB
    Neurology; 1988 Aug; 38(8):1255-62. PubMed ID: 2840604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].
    Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M
    Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
    Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
    Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and glioma therapy.
    Woolf EC; Scheck AC
    CNS Oncol; 2012 Sep; 1(1):7-10. PubMed ID: 25054292
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems of chemotherapy for glioma].
    Hirose Y
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):923-6. PubMed ID: 21751527
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of the deoxyglucose and glucose phosphorylation ratio and the lumped constant in rat brain and a transplantable rat glioma.
    Kapoor R; Spence AM; Muzi M; Graham MM; Abbott GL; Krohn KA
    J Neurochem; 1989 Jul; 53(1):37-44. PubMed ID: 2723662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxyglucose kinetics in a rat brain tumor.
    Graham MM; Spence AM; Muzi M; Abbott GL
    J Cereb Blood Flow Metab; 1989 Jun; 9(3):315-22. PubMed ID: 2715203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repurposing of Metabolic Agents in Malignant Glioma.
    Seliger C; Hau P
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.